These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29959331)

  • 1. The Hsp70 inhibitor 2-phenylethynesulfonamide inhibits replication and carcinogenicity of Epstein-Barr virus by inhibiting the molecular chaperone function of Hsp70.
    Wang H; Bu L; Wang C; Zhang Y; Zhou H; Zhang X; Guo W; Long C; Guo D; Sun X
    Cell Death Dis; 2018 Jun; 9(7):734. PubMed ID: 29959331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Inhibits Proliferation of Epstein-Barr Virus-Associated Human Nasopharyngeal Carcinoma Cells by Inhibiting EBV Nuclear Antigen 1 Expression.
    Liu L; Yang J; Ji W; Wang C
    Biomed Res Int; 2019; 2019():8592921. PubMed ID: 31687403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
    Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
    Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells.
    Zhou H; Liu Y; Wang C; Liu L; Wang H; Zhang Y; Long C; Sun X
    J Exp Clin Cancer Res; 2018 Aug; 37(1):192. PubMed ID: 30111354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt's lymphoma cells.
    Hong M; Murai Y; Kutsuna T; Takahashi H; Nomoto K; Cheng CM; Ishizawa S; Zhao QL; Ogawa R; Harmon BV; Tsuneyama K; Takano Y
    J Cancer Res Clin Oncol; 2006 Jan; 132(1):1-8. PubMed ID: 16180023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roscovitine inhibits EBNA1 serine 393 phosphorylation, nuclear localization, transcription, and episome maintenance.
    Kang MS; Lee EK; Soni V; Lewis TA; Koehler AN; Srinivasan V; Kieff E
    J Virol; 2011 Mar; 85(6):2859-68. PubMed ID: 21209116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells.
    Yin Q; Flemington EK
    Virology; 2006 Mar; 346(2):385-93. PubMed ID: 16343579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo dynamics of EBNA1-oriP interaction during latent and lytic replication of Epstein-Barr virus.
    Daikoku T; Kudoh A; Fujita M; Sugaya Y; Isomura H; Tsurumi T
    J Biol Chem; 2004 Dec; 279(52):54817-25. PubMed ID: 15498777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
    Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
    Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits the proliferation of human nasopharyngeal carcinoma cells via an Epstein-Barr virus nuclear antigen 1-dependent mechanism.
    Wang C; Wang H; Zhang Y; Guo W; Long C; Wang J; Liu L; Sun X
    Oncol Rep; 2017 Apr; 37(4):2109-2120. PubMed ID: 28259949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus nuclear antigen 1 (EBNA1) induced cytotoxicity in epithelial cells is associated with EBNA1 degradation and processing.
    Jones RJ; Smith LJ; Dawson CW; Haigh T; Blake NW; Young LS
    Virology; 2003 Sep; 313(2):663-76. PubMed ID: 12954232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGCG debilitates the persistence of EBV latency by reducing the DNA binding potency of nuclear antigen 1.
    Chen YL; Tsai HL; Peng CW
    Biochem Biophys Res Commun; 2012 Jan; 417(3):1093-9. PubMed ID: 22226960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.